Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Cash from Investing Activities (2016 - 2023)

Rein Therapeutics filings provide 8 years of Cash from Investing Activities readings, the most recent being -$96000.0 for Q4 2023.

  • For the quarter ending Q4 2023, Cash from Investing Activities fell 102.02% year-over-year to -$96000.0, compared with a TTM value of -$96000.0 through Sep 2024, down 100.46%, and an annual FY2023 reading of $16.2 million, down 38.79% over the prior year.
  • Cash from Investing Activities hit -$96000.0 in Q4 2023 for Rein Therapeutics, down from $542000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $11.6 million in Q1 2022, with the low at -$37.5 million in Q1 2021.
  • Median Cash from Investing Activities over the past 5 years was $3.9 million (2019), compared with a mean of $516750.0.
  • The largest YoY upside for Cash from Investing Activities was 730.53% in 2021 against a maximum downside of 2107.53% in 2021.
  • Year by year, Cash from Investing Activities stood at $4.8 million in 2019, then plummeted by 107.49% to -$357000.0 in 2020, then skyrocketed by 730.53% to $2.3 million in 2021, then soared by 111.64% to $4.8 million in 2022, then crashed by 102.02% to -$96000.0 in 2023.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$96000.0, $542000.0, and $8.5 million for Q4 2023, Q3 2023, and Q2 2023 respectively.